6 results match your criteria: "Larner College of Medicine Burlington Vermont USA.[Affiliation]"
Introduction: Pediatric head and neck (HN) trauma is an important contributor to pediatric morbidity, resulting in significant downstream consequences. Few studies provide epidemiological predictors of pediatric HN trauma on a national scale. The present study aims to identify risk factors of HN injury and mortality in the pediatric population.
View Article and Find Full Text PDFClonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?
EJHaem
June 2024
Department of Pathology The University of Vermont Larner College of Medicine Burlington Vermont USA.
Article Synopsis
- Primary large B-cell lymphomas (IP-LBCLs) occur in "immune-privileged" areas like the CNS, vitreoretina, and testes, where the immune response is weaker.
- These lymphomas typically have a poor prognosis with high chances of returning either at the same spot or another similar site.
- The case discussed features a man with two separate cases of LBCL in the CNS and testis, diagnosed over ten years apart, that were not genetically linked, indicating they were not the same type of cancer.
An example of ventilatory limitation during cardiopulmonary exercise testing in a patient with COPD.
Respirol Case Rep
May 2024
Department of Medicine, Pulmonary and Critical Care Medicine University of Vermont, Larner College of Medicine Burlington Vermont USA.
Article Synopsis
- A 64-year-old obese man with moderate COPD is experiencing ongoing shortness of breath (dyspnoea) despite being treated with long-acting bronchodilators.
- A cardiopulmonary exercise test (CPET) revealed his reduced physical capacity, poor oxygen use, and difficulties with gas exchange, indicating issues beyond just heart function.
- The CPET findings helped the doctor understand the reasons for the man's symptoms and allowed them to customize a more effective treatment plan.
Hairy cell leukemia with plasmacytoid morphology.
EJHaem
April 2024
NeoGenomics Aliso Viejo California USA.
COVID-19: A new barrier to treatment for opioid use disorder in the emergency department.
J Am Coll Emerg Physicians Open
April 2021
Division of Emergency Medicine, University of Vermont Larner College of Medicine Burlington Vermont USA.
Objective: Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED-initiated buprenorphine/naloxone and rapid access to outpatient treatment. We sought to determine the impacts of the coronavirus disease 2019 pandemic on STAR and the patients with opioid use disorder it serves.
Methods: We conducted a retrospective review of records comparing 2 periods: pre-pandemic (February 1, 2019-February 29, 2020) and pandemic (March 1, 2020-May 31, 2020).